Public Company News

Software provider K2fly has initiated a sweeping strategic review of its operations in a swift boardroom move designed to maximise the full potential of its innovative resource governance software solutions. After posting 13 quarters of increasing revenue on the trot, K2Fly has vowed not to sit on those laurels and has appointed Argonaut PCF and Atrico as joint advisors to steer its review.

Infinity Mining’s recent drilling in a big swarm of stacked Pilbara pegmatites has yielded assays of up to 2.1 per cent lithium oxide and supportive rubidium, caesium and tantalum values, with more work to come. The company says its campaign of eight reverse-circulation drillholes for 834m at its Tambourah South project in Western Australia produced several outstanding shallow lithium-caesium-tantalum intercepts.

Askari Metals has jagged a high of 24.5g/t gold in one rock-chip sample from its Myrnas Hill project in Western Australia’s East Pilbara region, while soil samples yielded up to 2g/t, 1.37g/t and other lower gold and nickel spikes. The company says the campaign also recorded elevated nickel responses of up to 1280 parts per million.

ASX-listed Gold Mountain has identified a series of lithium anomalies from stream-sediment sampling at its Logradouro project in Brazil, where the company has mapped 250 pegmatites across its two-tenement site. Management says the sampling results indicate the presence of lithium-caesium-tantalum pegmatites within the operation, with soil sampling set to follow up on selected anomalies to define drill targets.

Gold Mountain is aiming to more than double the size of its Green River copper-gold project in Papua New Guinea after lodging an application for a 552sq-km tenement adjacent to a previous 501sq-km application. Management says high-grade copper-gold and lead-zinc rock-chip samples have been found in the tenements by previous explorers, with target areas for follow-up exploration already identified.

A research and development tax rebate of nearly $5 million from the Australian Government will boost Radiopharm Theranostics’ mission to further develop its suite of diagnostic and therapeutic products aimed at beating the cancer scourge. The refund recognises the company’s R&D activity during the 2023 financial year and comes as it prepares to run clinical pancreatic cancer trials in New York.

Aruma Resources says it has uncovered the presence of a high-grade gold-bearing structure in the latest phase of drilling at the company’s Salmon Gums project in Western Australia’s Eastern Goldfields region. Assay highlights returned a 5.9m intercept grading 10.5 grams per tonne gold from 38.4m, including 2.6m going 9.85g/t gold from 38.4m and 0.85m at an impressive 40.9g/t gold from 43.4m.

Two diamond-core holes drilled by Alma Metals into the central zone of its Briggs porphyry copper-molybdenum project in Central Queensland have defined thick mineralisation extending from surface through almost the full 200m hole depths. The company says its latest results further support the possibility for bringing to life its previous visions of a shallow, high-grade initial open pit.

Buru Energy’s wholly-owned hydrogen-chasing business 2H Resources has picked up hydrogen and helium-prospective ground in South Australia – right next to the nation’s first discovery well for the natural gas. The company is now the preferred applicant for seven petroleum and two gas exploration licences in SA, with its WA helium and hydrogen hunt expanding into six new “special prospecting authorities with an acreage option”.

ChemX Materials has received more than $900,000 through a research and development tax incentive rebate payment for developing its high-purity manganese and alumina projects during the past financial year. Administered by AusIndustry and the Australian Tax Office, the rebate is available for companies investing in research and development programs aimed at sustainably producing critical minerals for the future.

Reach Resources has sprung back into drilling action at its Morrissey Hill lithium project in Western Australia’s emerging Gascoyne region to double down on the area’s pegmatite potential following phase-one drill results. Its 9000m RC program will test the extension of multiple thick, stacked lithium-bearing pegmatites at its Bonzer prospect, in addition to six of 50 undrilled pegmatite targets mapped during fieldwork.

Chimeric Therapeutics expects a phase-1B clinical trial into its “natural killer” cell therapy for newly-diagnosed patients with acute myeloid leukemia to be open for new enrolments before the end of the year. The study, which has received investigational new drug clearance from the USFDA, is designed to enrol up to 20 patients who are not eligible for intensive chemotherapy or allogeneic stem cell transplant.